Stay updated on VX-659 Combo in F/MF CF: Clinical Trial
Sign up to get notified when there's something new on the VX-659 Combo in F/MF CF: Clinical Trial page.

Latest updates to the VX-659 Combo in F/MF CF: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe Study Details page now includes an expanded list of study locations (US states and Canadian provinces) and adds a revision tag (v3.3.3). The HHS Vulnerability Disclosure link and the previous set of location entries were removed.SummaryDifference2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision label on the page was updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check46 days agoChange DetectedNotice regarding government funding and operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check60 days agoChange DetectedMinor UI/layout adjustments are visible in the Study Overview and Study Plan sections; the core study data such as title, inclusion criteria, primary outcomes, and enrollment remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check89 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference3%

- Check96 days agoChange DetectedAppended version label (v3.1.0) and removal of multiple drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.SummaryDifference0.4%

Stay in the know with updates to VX-659 Combo in F/MF CF: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX-659 Combo in F/MF CF: Clinical Trial page.